Global Kaempferol Market Set for Significant Growth, Expected to Reach $4.96 Billion by 2028

June 28, 2024 12:10 AM AEST | By EIN Presswire
 Global Kaempferol Market Set for Significant Growth, Expected to Reach $4.96 Billion by 2028
Image source: EIN Presswire

LONDON, GREATER LONDON , UK, June 27, 2024 /EINPresswire.com/ -- The global kaempferol market has demonstrated robust growth in recent years, expanding from $3.92 billion in 2023 to an expected $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. It will grow to $4.96 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%.This growth is driven by advancements in plant-based nutrition research, biomedical and pharmacological studies, increased focus on antioxidants, biotechnological progress, and botanical and phytochemical studies.

Increasing Cancer Prevalence Fuels Market Growth
The increasing prevalence of cancer is a significant driver of the kaempferol market's expansion. Cancer, characterized by the uncontrolled growth of abnormal cells, often spreads to other organs or tissues. Kaempferol, a phytoestrogen from plants, combats cancer by inducing apoptosis, halting the cell cycle, and preventing blood vessel development and migration of cancer cells. For example, a 2022 report by the American Cancer Society highlighted a rise in new cancer cases in the US, from 1.89 million in 2021 to 1.92 million in 2022. This increasing incidence of cancer is driving the demand for kaempferol.

Explore comprehensive insights into the global kaempferol market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=12351&type=smp

Major Companies and Market Trends
Key players in the kaempferol market include Fujifilm Wako Pure Chemical Corporation, Merk Millipore, LGC Group, Abcam PLC, ChromaDex Corporation, Cayman Chemical Company, BioVision Inc., Clearsynth Labs Ltd., Enzo Life Sciences Inc., Santa Cruz Biotechnology Inc., AppliChem GmbH, Conagen Inc., MedChemExpress LLC, BioBioPha Co. Ltd., FoodChem International Corporation, Oakwood Products Inc., Spectrum Chemical Mfg. Corp., Aktin Chemicals Inc., BOC Sciences, AK Scientific Inc., Chemfaces Biochemical Co. Ltd., INDOFINE Chemical Company Inc., Risun Bio-Tech Inc., Shaanxi NHK Technology, and TCI Chemicals (India) Pvt. Ltd.

Kaempferol Market Trends in the Market
Product innovations are a key trend gaining popularity in the kaempferol industry. Major companies are developing innovative products to maintain their market positions. For instance, in January 2022, Conagen, a US-based biotechnology company, developed antioxidant kaempferol using state-of-the-art precision fermentation. This method is more efficient and environmentally friendly than traditional chemical synthesis or botanical sourcing. Conagen's kaempferol can be used in formulations for nutrition, cosmetics, and personal care products, promoting a more natural approach.

Kaempferol Market Segments:
The kaempferol market covered in this report is segmented –
1) By Source: Tea, Fruits, Vegetables, Medicinal Plants
2) By Purity: 10%, 20%, 50%,95%,98%
3) By Application: Food And Beverages, Cosmetics, Pharmaceuticals, Dietary Supplements, Other Applications

Geographical Insights: North America Leading the Market
North America was the largest region in the kaempferol market in 2023, while Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the kaempferol market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/kaempferol-global-market-report

Kaempferol Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Kaempferol Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on kaempferol market size, kaempferol market drivers and trends, kaempferol market major players, competitors' revenues, market positioning, and market growth across geographies. The kaempferol market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Plant Extracts Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/plant-extracts-global-market-report

Plant-Based Protein Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/plant-based-protein-global-market-report

Plant Breeding And CRISPR Plants Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.